UnitedHealth Group Incorporated (NYSE:UNH) had its price target increased by Cantor Fitzgerald to $225.00 in a report issued on Wednesday. The firm currently has an overweight rating on the healthcare conglomerate’s stock.

UNH has been the subject of a number of other reports. Barclays PLC lifted their price target on shares of UnitedHealth Group from $200.00 to $217.00 and gave the stock an overweight rating in a research note on Wednesday, July 19th. Zacks Investment Research upgraded shares of UnitedHealth Group from a hold rating to a buy rating and set a $219.00 price target for the company in a research note on Thursday, September 21st. Cowen and Company reiterated a buy rating on shares of UnitedHealth Group in a research note on Friday, July 14th. Jefferies Group LLC reiterated a buy rating and issued a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. Finally, BidaskClub lowered shares of UnitedHealth Group from a strong-buy rating to a buy rating in a research note on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of Buy and a consensus target price of $215.27.

Shares of UnitedHealth Group (NYSE UNH) traded down 0.70% during mid-day trading on Wednesday, hitting $203.80. 2,443,443 shares of the company were exchanged. The company has a 50 day moving average of $196.96 and a 200 day moving average of $185.50. The company has a market capitalization of $201.56 billion, a P/E ratio of 23.14 and a beta of 0.63. UnitedHealth Group has a 52 week low of $133.03 and a 52 week high of $207.80.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period in the previous year, the business posted $2.17 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group will post $9.91 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Price Target Increased to $225.00 by Analysts at Cantor Fitzgerald” was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://theolympiareport.com/2017/10/19/unitedhealth-group-incorporated-unh-price-target-increased-to-225-00-by-analysts-at-cantor-fitzgerald.html.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.46%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders sold 76,174 shares of company stock worth $14,981,909 in the last three months. Insiders own 0.89% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC raised its stake in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares in the last quarter. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group during the second quarter valued at $110,000. Kings Point Capital Management raised its stake in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares in the last quarter. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group during the second quarter valued at $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. 86.11% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.